Physician profile
John Lapelusa
NPI 1639631856
$54,002.77
in general payments reported to CMS, 2019-2025
23 companies · $44K in 2025
The $44K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,691 · 2023: $2,047 · 2024: $2,913 · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Travel and Lodging: $8,480 · Food and Beverage: $6,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,410.00 |
| Travel and Lodging | $8,480.32 |
| Food and Beverage | $6,421.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $44,386.12 | 2022-2025 | |
| Stryker Corporation | $3,119.74 | 2022-2024 | Augment Injectable, Omega, 7 X 23mm Citrelock Implant |
| Organogenesis INC. | $1,206.44 | 2023-2025 | Puraply, Affinity, Affinity |
| Novus Surgical Solutions LLC | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $959.01 | 2023-2025 | Stravix Pl, Stravix, Collagenase Santyl |
| Novus Surgical Consultants | $905.29 | 2022-2025 | |
| Arthrex, INC. | $621.16 | 2023 | |
| Averitas Pharma INC. | $344.09 | 2023-2024 | Qutenza |
| Biotissue Holdings INC. | $264.57 | 2022 | |
| Integra Lifesciences Corporation | $251.97 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paragon 28, INC. | $134.98 | 2022-2023 | Mtp |
| Mvp Orthopedics INC | $107.73 | 2022 | |
| Convatec INC. | $100.85 | 2023 | |
| Trice Medical, INC. | $80.80 | 2024 | |
| Solventum Corporation | $76.14 | 2024-2025 | Activ.A.C. |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $65.87 | 2023 | |
| Medtronic, INC. | $44.36 | 2025 | Inceptiv |
| Paratek Pharmaceuticals, INC. | $40.97 | 2022 | |
| Kci USA, INC. | $24.30 | 2023 | V.A.C. Dermatac, Promogran Prisma, Activ.A.C. |
| Vertex Pharmaceuticals Incorporated | $22.81 | 2025 | |
| Nevro Corp. | $16.12 | 2023 | Senza |
| Bioventus LLC | $15.02 | 2024 | Exogen Ultrasound Bone Healing System |
| Biocomposites INC | $14.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lapelusa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.